Share Price | Minerva Surgical, Inc. Stock Analysis & Recommendation

Q: How big is Minerva Surgical, Inc.?

Market Cap: As of Jun 18, Minerva Surgical, Inc. has a market capitalization of 0.00, categorizing it as a Micro Cap.Recent Quarterly Performance: For the latest four quarters, Minerva Surgical, Inc. reported net sales of 51.68 million. However, the company experienced a net profit loss of 33.45 million during the same period.Balance Sheet Snapshot: As of Dec 22, the company's shareholder's funds amounted to 17.18 million, while total assets were reported at 68.90 million.

Q: Is Minerva Surgical, Inc. overvalued or undervalued?

As of 11 May 2022, the valuation grade for Minerva Surgical, Inc. has moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its current metrics, particularly with a P/E ratio of 0.00, an EV to EBIT of -0.85, and an EV to EBITDA of -1.14, which suggest a lack of profitability and operational efficiency. In comparison to its peers, Silk Road Medical, Inc. has a P/E ratio of -19.76 and an EV to EBITDA of -18.12, while Cytek Biosciences, Inc. shows a P/E of -33.33 and an EV to EBITDA of -15.41, both indicating that Minerva Surgical is underperforming relative to its industry. Additionally, the company's one-year return of -99.17% starkly contrasts with the S&P 500's return of 17.14%, reinforcing the notion that Minerva Surgical is struggling significantly in the market.

Q: Is Minerva Surgical, Inc. technically bullish or bearish?

As of 13 June 2025, the technical trend for Minerva Surgical, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows a bullish monthly reading but none on the weekly. Moving averages indicate a mildly bearish daily trend. Additionally, the KST is bearish on the weekly and neutral on the monthly, and Dow Theory shows no trend in both time frames. In terms of performance, the company has significantly underperformed the S&P 500 over the past year, with a return of -99.17% compared to the S&P 500's 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Dec 2023)

FII

1.06%

Held by 4 FIIs

DII

75.73%

Held by 1 DIIs

Promoter

22.66%

How big is Minerva Surgical, Inc.?

22-Jun-2025

As of Jun 18, Minerva Surgical, Inc. has a market capitalization of 0.00, categorizing it as a Micro Cap, with net sales of 51.68 million and a net profit loss of 33.45 million over the latest four quarters. As of Dec 22, the company's shareholder's funds were 17.18 million, and total assets were 68.90 million.

View full answer

Is Minerva Surgical, Inc. overvalued or undervalued?

20-Sep-2025

As of May 11, 2022, Minerva Surgical, Inc. is rated as risky due to its overvaluation and poor financial metrics, including a P/E ratio of 0.00 and a one-year return of -99.17%, significantly underperforming compared to its peers and the S&P 500.

View full answer

Is Minerva Surgical, Inc. technically bullish or bearish?

20-Sep-2025

As of June 13, 2025, Minerva Surgical, Inc. shows a neutral technical trend with mixed indicators, including a mildly bullish MACD and bearish KST, while significantly underperforming the S&P 500 with a return of -99.17% compared to its 17.14%.

View full answer

Compare Minerva Surgical, Inc. with Similar Stocks

BioLife Solutions, Inc.Silk Road Medical, Inc.Artivion, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD Million (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

1.43

Return on Equity

-189.83%

Price to Book

0.00

Revenue and Profits:

Net Sales:

12 Million

(Quarterly Results - Sep 2023)

Net Profit:

-7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-100.0%

6 Months

-100.0%

1 Year

0.0%

2 Years

-100.0%

3 Years

-100.0%

4 Years

-100.0%

5 Years

0.0%

Minerva Surgical, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

24.60%

EBIT Growth (5y)

-133.07%

EBIT to Interest (avg)

-9.54

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.43

Sales to Capital Employed (avg)

2.33

Tax Ratio

0.16%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

25.65%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-0.85

EV to EBITDA

-1.14

EV to Capital Employed

0.59

EV to Sales

0.56

PEG Ratio

Dividend Yield

ROCE (Latest)

-69.62%

ROE (Latest)

-189.83%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

Bollinger Bands

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 8 Schemes (0.55%)

Foreign Institutions

Held by 4 Foreign Institutions (1.06%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2023 is -4.76% vs 0.80% in Sep 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2023 is 36.28% vs -253.12% in Sep 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Sep'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.00",
          "val2": "12.60",
          "chgp": "-4.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.70",
          "val2": "-7.70",
          "chgp": "38.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "0.90",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.20",
          "val2": "-11.30",
          "chgp": "36.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-509.50%",
          "val2": "-834.80%",
          "chgp": "32.53%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is -3.45% vs 37.83% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -58.60% vs -17.49% in Dec 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.30",
          "val2": "52.10",
          "chgp": "-3.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-28.60",
          "val2": "-18.10",
          "chgp": "-58.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.20",
          "val2": "11.70",
          "chgp": "-72.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.10",
          "val2": "19.60",
          "chgp": "-53.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-34.10",
          "val2": "-21.50",
          "chgp": "-58.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-795.20%",
          "val2": "-551.20%",
          "chgp": "-24.40%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY

Sep'23

Sep'22

Change(%)

Net Sales

12.00

12.60

-4.76%

Operating Profit (PBDIT) excl Other Income

-4.70

-7.70

38.96%

Interest

1.20

0.90

33.33%

Exceptional Items

0.00

Consolidate Net Profit

-7.20

-11.30

36.28%

Operating Profit Margin (Excl OI)

-509.50%

-834.80%

32.53%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2023 is -4.76% vs 0.80% in Sep 2022

Consolidated Net Profit

YoY Growth in quarter ended Sep 2023 is 36.28% vs -253.12% in Sep 2022

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

50.30

52.10

-3.45%

Operating Profit (PBDIT) excl Other Income

-28.60

-18.10

-58.01%

Interest

3.20

11.70

-72.65%

Exceptional Items

9.10

19.60

-53.57%

Consolidate Net Profit

-34.10

-21.50

-58.60%

Operating Profit Margin (Excl OI)

-795.20%

-551.20%

-24.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is -3.45% vs 37.83% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -58.60% vs -17.49% in Dec 2021

All Annual Results

Company CV

About Minerva Surgical, Inc.

Minerva Surgical, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Minerva Surgical, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Minerva Surgical, Inc.?

Watch in Real-Time

Is Minerva Surgical, Inc. overvalued or undervalued?

Is Minerva Surgical, Inc. technically bullish or bearish?

Compare Minerva Surgical, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY

Annual Results Snapshot (Consolidated) - Dec'22

About Minerva Surgical, Inc.

Company Coordinates